BGM Group announced completion of the acquisition of the intelligent platform of AIX. It marks BGM’s official entry into the domains of AI intelligent technology and financial/insurance services, opening up new opportunities for the integrated development of healthcare, pharmaceuticals, and insurance on a global scale. Through the acquisition of RONS Technology and Xinbao Investment, BGM will be able to integrate resources in intelligent technology and biopharmaceuticals, strengthening its market competitiveness at the intersection of healthcare technology and insurance technology. This will enable the Company to offer more comprehensive and intelligent health and insurance service solutions to users, while simultaneously pioneering the synergistic development of ‘healthcare, pharmaceuticals, and insurance’ on a global scale, further enhancing its global influence.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on BGM:
- AIX completes share exchange with BGM Group
- BGM Group Ltd trading resumes
- BGM Group Ltd trading halted, volatility trading pause
- Qilian International’s Strategic Transaction and Reorganization
- BGM Group, AIX enter strategic transaction agreement
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
